Trends in angiotensin receptor/neprilysin inhibitor (ARNI) prescribing across multi-Centre, multi-ethnic heart failure population

Background: Angiotensin receptor-neprilysin inhibitors (ARNIs) are recommended in clinical guidelines for the management of heart failure with reduced ejection fraction (HFrEF) due to their proven benefits in reducing mortality and hospitalization rates. However, real-world data on the use, and dos...

Full description

Bibliographic Details

Main Authors:	C Chelfi Zhi, Fei Chua, B. K., Chung, Hwei Sung, Ling, K. C., Cheah, S. L., Kwa, J., Namasoo, C. H., ChaI, P. W., Ting, M. J., Khaw, J. K.W., Wong, A.Z. Y., Koh, W. K., Ho, L. Y., Ting, S. Y., Chai, R.S.L., Chew
Format:	Article
Language:	en
Published:	European Society of Cardiology 2025
Subjects:	R Medicine (General)
Online Access:	http://ir.unimas.my/id/eprint/50364/3/Trends%20in%20angiotensin.pdf http://ir.unimas.my/id/eprint/50364/ https://onlinelibrary.wiley.com/toc/18790844/2025/27/S2
Tags:	Add Tag No Tags, Be the first to tag this record!